Karolinska Institutet
Stockholm, Sweden
NCT Number: NCT06420453
"How long will my labor last" is a very common question for midwives who care for women during birth. To evaluate safe labor duration largely determines management and care during birth. Today a standardized tool is used by midwives to evaluate normal and safe labor called the partograph. The World Health Organization partograph is a decision-making support tool designed to assist midwives in identifying normal labor duration and women at risk of developing complications. The tool guide the use of care interventions intended to mitigate any perceived risks. The partograph has been in use since the 1950ies and has had a profound impact on care and management during labor. Normal labor progression according to the partograph is a linear progression with cervical dilation of 1 centimeter per hour (alert line) and any deviation from this should lead to an intervention.The purpose of this research project is to increase person-centred care during labor. Specifically, we want to provide updated comprehensive information on labor duration and patient safety for reduction of; unnecessary medical interventions during normal labor; morbidity and mortality in the new-born; maternal complications during delivery and the puerperal period.
Looking for future studies?
Notify MeAll sexes
Observational
Stockholm, Sweden
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
All births with labor duration
Exclusion criteria
Elective Cesarean birth
Time frame: 1 month postpartum
Time frame: 1 month postpartum
Karolinska Institutet
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06387680
Apgar; 4-7 at 1 Minute, Birth Outcome, Adverse
Konya, Turkey (Türkiye)
View Trial DetailsNCT06502119
Birth Injuries, Birth Outcome, Adverse
Cairo, Cairo Governorate, Egypt
View Trial DetailsNCT06508554
Birth Outcome, Adverse, Female Urogenital Diseases and Pregnancy Complications
Bartın, Turkey (Türkiye)
View Trial DetailsNCT06551571
Behavior, Birth Outcome, Adverse
Konya, Turkey (Türkiye)
View Trial Details